China's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety
With the coming Oil & Gas Asia Exhibition in Pakistan, ECHEMI rolls out a new bulk purchasing activity for its new and old customers. This activity will be valid before March 16 when the exhibition come to the end. The more you buy, the more money you will save.
How to join this bulk purchasing?
You can enjoy the most favorable prices via three steps:
First, you should come to the home page of ECHEMI, then you can see the the following page:
Second, input your demand and submit the inquiry.
Third, ECHEMI will give you a reply within 1 working day after receiving your inquiry.
Opportunity knocks but once! Come on, seize this opportunity right now!
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-07-02
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
GlaxoSmithKline Pharmaceuticals Reports 11% Rise in Q1 Profit Driven by Strong Demand for Vaccines
-
How far behind is the vaccine industry?
-
Cambi, Wood & Sasol to convert bio sludge into hydrocarbon fuel
-
Global Vaccine Market Rises to the TopAgain
-
Pfizer's paxlovid reduces the risk of COVID-19 by 26%
-
The battle between Pfizer and Gilead over COVID-19 drugs will continue
-
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease
-
The domestic nine-valent HPV vaccine race is underway: These companies' vaccines have entered the clinical phase three stage
-
Legendary Bio BCMA CAR-T approved for sale in Japan
-
USA丨Peptyde Bio targets high costs and chemical-resistant pests with new bio-fungicide platform
Recommend Reading
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
February Butadiene Rubber Market Trend Weakly Fluctuates in China
-
Weak Trading, ABS Operates at Low Levels in Early September in China
-
Uses of Dithiothreitol in Laboratories
-
October Palm Oil Market Fluctuates and Falls
-
Bulls and Bears Intertwined: Palm Oil Prices Weaken in February